Physician profile
Kimyatta Morris
NPI 1306604889
$2,500.93
in general payments reported to CMS, 2019-2025
8 companies · $2,280 in 2025
The $2,280 reported for 2025 was more than what 96% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $221 · 2025: $2,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,424 · Food and Beverage: $1,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,424.47 |
| Food and Beverage | $1,076.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,971.09 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Davol INC. | $142.70 | 2024-2025 | Arista, Arista Ah Flexitip |
| Getinge USA Sales, LLC | $129.11 | 2025 | Vasoview Hemopro 2 |
| Medical Device Business Services, INC. | $117.64 | 2024 | Stratafix, Vistaseal |
| Arthrex, INC. | $59.54 | 2024 | |
| Edwards Lifesciences Corporation | $42.94 | 2025 | Mitris Resilia Mitral Valve |
| Heartflow, INC. | $19.97 | 2025 | |
| Stryker Corporation | $17.94 | 2025 | Spy-Phi System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimyatta Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.